Perspective Therapeutics · 2 weeks ago
Lead Scientist – Sterile Formulations Development
Perspective Therapeutics is seeking a highly motivated hands-on scientist with expertise in sterile injectable drug products to join our dynamic CMC drug product team. This role is critical in supporting the development of sterile injectable formulations and drug product process development from early development through scale-up and commercial manufacturing.
Responsibilities
Serve as the technical subject matter expert (SME) for formulation and drug product process development
Conduct formulation/process development studies, including comparability, stability, and compatibility assessments
Lead scale-up and technology transfer activities to support manufacturing
Draft detailed study plans to ensure that work is performed efficiently and in a scientifically sound manner
Monitor experiments (e.g. process development, formulation optimization) and ensure complex data are interpreted in a scientifically correct way
Support filter and container closure integrity validation studies and other special studies as necessary
Collaborate with cross-functional teams including Analytical, Quality, Regulatory, and Manufacturing
Author formulation and process development reports, study protocols, and regulatory CMC module 3 documentation to support late-stage IND and NDA submissions
Ensure all work is performed in accordance with company policies, procedures and safety standards
Ensure documents follow relevant regulatory standards (e.g., FDA, USP, ICH) and CMC guidelines
Troubleshoot and propose scientifically sound solutions in collaboration with internal teams
Provide technical support during regulatory inspections and audits, as needed
Qualification
Required
Ph.D. or M.S. or B.S. in Pharmaceutics, Chemistry, or related field
5-7 years of hands-on experience in formulation development and sterile drug product process development using quality by design (QbD) principles
Strong understanding of aseptic processing, formulation characterization, excipient compatibility, and container-closure systems
Experience with QbD principles and risk-based development approaches
Pharmaceutical product life cycle management
Deep expertise in regulatory frameworks (FDA, EMA), and clinical/commercial manufacturing
Familiarity with GMP quality systems and electronic document management systems
Ability to prepare detailed study protocols and interpret complex data sets across multiple techniques
Excellent communication skills, including the ability to explain technical concepts to cross-functional teams
Strong organizational skills, with the ability to manage multiple priorities and meet tight deadlines
Work independently and proactively in a highly matrixed environment
Must be willing to work in a facility producing radioactive materials and requiring all employees to participate in safety programs designed to minimize potential and/or actual exposure levels
May be required to sit or stand for long periods of 8+ hours a day while performing duties
Willingness to complete safety training within allotted time limits, and work in a team-based environment
May require travel to Iowa up to 10%
Preferred
Experience in radiopharmaceuticals or isotope-based therapeutics is strongly preferred
Prior radiochemistry experience and knowledge of radioactive material handling are a plus
Company
Perspective Therapeutics
Perspective Therapeutics focuses on advancing cancer treatments employing radiation, radiopharmaceuticals, and imaging technology.
H1B Sponsorship
Perspective Therapeutics has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (3)
Funding
Current Stage
Public CompanyTotal Funding
$257.6MKey Investors
National Institutes of Health
2024-05-24Post Ipo Equity· $80M
2024-03-04Post Ipo Equity· $87.4M
2024-02-01Grant· $0.4M
Recent News
FiercePharma
2026-01-12
Perspective Therapeutics, Inc.
2025-12-04
Company data provided by crunchbase